7ZN-73501-88210
4 vaccinations
2 coded responses
5 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 606 / IL
- Registered
- 2022-09-21
- Relationship
- Child or adolescent in my care
- Guardian
- DVY-14029-96962
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-05
Dose 1 — Pfizer-BioNTech
-
2021-11-27
Dose 2 — Pfizer-BioNTech
-
2022-05-20
Dose 3 — Pfizer-BioNTech
-
2022-09-21
Registered in v-safe
-
2023-03-06
Dose 4 — Pfizer-BioNTech
- 2023-03-22
-
2023-03-27
Survey response — day 21, dose 4, dependentMedDRA: Headache, Nasal congestion, Pain — Feeling: PoorMedDRA releases: 2024-11
- 2023-04-03
- 2023-04-10
-
2023-06-05
Survey response — 3 months, dose 4, dependentMedDRA: Fatigue, Headache, Nasal congestion, Oropharyngeal pain, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-05 | Pfizer-BioNTech | No |
| 2 | 2021-11-27 | Pfizer-BioNTech | No |
| 3 | 2022-05-20 | Pfizer-BioNTech | No |
| 4 | 2023-03-06 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release